CID 16131952

Hiv-1 12-mer tar rna containing 2'-o-methyl and 2',4'-locked nucleotides: [5'-lna(c)-2'-ome(u)-lna(c)-lna(c)-lna(c)-2'-ome(a)-lna(g)-2'-ome(g)-lna(c)-2'-ome(u)-lna(c)-2'-ome(a)-l-homoserine-6-carboxyfluorescein]

Structural Information

Molecular Formula
C155H184N44O92P12
SMILES
CC1=CN(C(=O)N=C1N)C2C3C(C(O2)(CO3)CO)OP(=O)(O)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)OC)OP(=O)(O)OCC67COC(C6OP(=O)(O)OCC89COC(C8OP(=O)(O)OCC12COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C(N=CN=C31)N)OC)OP(=O)(O)OCC13COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC4=C1N=C(NC4=O)N)OC)OP(=O)(O)OCC14COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)OP(=O)(O)OCC15COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC6=C(N=CN=C61)N)OC)OP(=O)(O)OCC[C@@H](C(=O)N)NC(=O)C1=CC6=C(C=C1)C(=O)OC61C6=C(C=C(C=C6)O)OC6=C1C=CC(=C6)O)C(O5)N1C=C(C(=NC1=O)N)C)C(O4)N1C=C(C(=NC1=O)N)C)C(O3)N1C=NC3=C1N=C(NC3=O)N)C(O2)N1C=C(C(=NC1=O)N)C)C(O9)N1C=C(C(=NC1=O)N)C)C(O7)N1C=C(C(=NC1=O)N)C
InChI
InChI=1S/C155H184N44O92P12/c1-58-27-190(142(212)178-109(58)156)130-95-102(148(38-200,272-130)39-247-95)285-293(220,221)255-33-74-85(90(242-7)125(267-74)188-21-18-79(203)176-140(188)210)281-299(232,233)262-48-151-42-251-99(134(275-151)194-31-62(5)113(160)182-146(194)216)106(151)290-303(240,241)265-51-153-44-252-100(135(277-153)195-32-63(6)114(161)183-147(195)217)107(153)291-302(238,239)264-50-152-43-250-98(133(276-152)193-30-61(4)112(159)181-145(193)215)105(152)288-296(226,227)258-36-77-88(93(245-10)128(270-77)197-55-172-82-116(163)168-53-170-119(82)197)283-301(236,237)263-49-154-45-253-101(136(278-154)199-57-174-84-121(199)185-139(166)187-124(84)208)108(154)289-297(228,229)259-37-78-89(94(246-11)129(271-78)198-56-173-83-120(198)184-138(165)186-123(83)207)284-300(234,235)261-47-150-41-249-96(131(274-150)191-28-59(2)110(157)179-143(191)213)103(150)286-294(222,223)256-34-75-86(91(243-8)126(268-75)189-22-19-80(204)177-141(189)211)282-298(230,231)260-46-149-40-248-97(132(273-149)192-29-60(3)111(158)180-144(192)214)104(149)287-295(224,225)257-35-76-87(92(244-9)127(269-76)196-54-171-81-115(162)167-52-169-118(81)196)280-292(218,219)254-23-20-71(117(164)205)175-122(206)64-12-15-67-70(24-64)155(279-137(67)209)68-16-13-65(201)25-72(68)266-73-26-66(202)14-17-69(73)155/h12-19,21-22,24-32,52-57,71,74-78,85-108,125-136,200-202H,20,23,33-51H2,1-11H3,(H2,164,205)(H,175,206)(H,218,219)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H,238,239)(H,240,241)(H2,156,178,212)(H2,157,179,213)(H2,158,180,214)(H2,159,181,215)(H2,160,182,216)(H2,161,183,217)(H2,162,167,169)(H2,163,168,170)(H,176,203,210)(H,177,204,211)(H3,165,184,186,207)(H3,166,185,187,208)/t71-,74?,75?,76?,77?,78?,85?,86?,87?,88?,89?,90?,91?,92?,93?,94?,95?,96?,97?,98?,99?,100?,101?,102?,103?,104?,105?,106?,107?,108?,125?,126?,127?,128?,129?,130?,131?,132?,133?,134?,135?,136?,148?,149?,150?,151?,152?,153?,154?/m0/s1
InChIKey
XBROCGLTLWBIKI-VBUGWDDDSA-N
Compound name
[3-[[7-[[7-[[7-[[3-[[7-[[3-[[7-[[3-[[7-[[3-[[(3S)-4-amino-3-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]-4-oxobutoxy]-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(2-amino-6-oxo-1H-purin-9-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methyl [3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4504.7925 Da
Monoisotopic Mass

-30.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4505.7998 312.1
[M+Na]+ 4527.7817 312.3
[M-H]- 4503.7852 312.1
[M+NH4]+ 4522.8263 312.1
[M+K]+ 4543.7557 312.1
[M+H-H2O]+ 4487.7898 311.9
[M+HCOO]- 4549.7907 312.1
[M+CH3COO]- 4563.8064 312.1
[M+Na-2H]- 4525.7672 312.3
[M]+ 4504.7920 312.2
[M]- 4504.7930 312.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.